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The propagation of pluripotential mouse embryonic stem (ES) cells is sustained by leukemia inhibitory factor (LIF) or related
cytokines that act through a common receptor complex comprising the LIF receptor subunit (LIF-R) and the signal transducer
gp130. However, the findings that embryos lacking LIF-R or gp130 can develop beyond gastrulation argue for the existence of an
alternative pathway(s) governing the maintenance of pluripotency in vivo. In order to define those factors that contribute to
self-renewal in ES cell cultures, we have generated ES cells in which both copies of the lif gene are deleted. These cells showed
a significantly reduced capacity for regeneration of stem cell colonies when induced to differentiate, confirming that LIF is the
major endogenous regulatory cytokine in ES cell cultures. However, self-renewal was not abolished and undifferentiated ES cell
colonies were still obtained in the complete absence of LIF. A differentiated, LIF-deficient, parietal endoderm-like cell line was
derived and shown to support ES cell propagation via production of a soluble, macromolecular, trypsin-sensitive activity. This
activity, which we name ES cell renewal factor (ESRF), is distinct from members of the IL-6/LIF family because (i) it is effective
on ES cells lacking LIF-R; (ii) it is not blocked by anti-gp130 neutralizing antibodies; and (iii) it acts without activation of STAT3.
ES cells propagated clonally using ESRF alone can contribute fully to chimaeras and engender germline transmission. These
findings establish that ES cell pluripotency can be sustained via a LIF-R/gp130-independent, STAT-3 independent, signaling
pathway. Operation of this pathway in vivo could play an important role in the regulation of pluripotency in the epiblast and
account for the viability of lifr 2/2 and gp130 2/2 embryos. © 1998 Academic Press
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INTRODUCTION
Embryonic stem (ES) cells are diploid pluripotential cell
lines established from early mouse embryos (Evans and Kauf-
man, 1981; Martin, 1981; Brook and Gardner, 1997). These
cells will participate fully in normal embryogenesis following
reintroduction into blastocysts and can contribute functional
differentiated progeny to all somatic tissues and to the germ
line (Bradley et al., 1984). The latter property is now widely
exploited for mutagenesis of the mouse germline (Robertson,
1986; Capecchi, 1989; Hooper, 1992). ES cells can also be
induced to differentiate into a wide variety of cell types in
culture, recapitulating in vitro developmental processes re-
sponsible for tissue diversification in the developing embryo.
ES cells therefore provide a powerful system for the analysis of
factors that control early embryonic growth and differentia-
tion (Heath and Smith, 1988; Smith, 1992).
Previous investigation of requirements for ES cell propa-
gation led to the discovery and purification of a secreted
factor named differentiation inhibiting activity or DIA
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(Smith and Hooper, 1987; Smith et al., 1988). This is
identical to the pleiotropic cytokine originally called D
factor (Tomida et al., 1984) and now more commonly
known as leukemia inhibitory factor (LIF) (Gearing et al.,
1987; Williams et al., 1988). LIF acts to sustain the self-
renewal of undifferentiated ES cells and thereby allows
their propagation in vitro. ES cells maintained in the
presence of this factor retain their full development poten-
tial. Moreover, ES cells can be established de novo by direct
culture of early embryos in medium supplemented with LIF
(Nichols et al., 1990; Pease et al., 1990).
Cellular responses to LIF are initiated by heterodimeriza-
tion of two members of the cytokine receptor family, the
low-affinity LIF-receptor (LIF-R) and gp130 (Gearing et al.,
1991; Gearing et al., 1992; Davis et al., 1993). LIF-R and
gp130 are both components of receptor complexes for a
number of cytokines, including LIF, ciliary neurotrophic
factor (CNTF), oncostatin M (OSM), and cardiotrophin-1
(CT-1) (Gearing et al., 1992; Davis et al., 1993; Pennica et
al., 1995). The utilization of common receptor subunits
results in considerable overlap in biological activities
among these cytokines (Kishimoto et al., 1994). Accord-
ingly, CNTF, OSM, or CT-1 can each substitute for LIF and
support propagation of undifferentiated ES cells (Conover et
al., 1993; Nichols et al., 1994; Rose et al., 1994; Wolf et al.,
1994; Pennica et al., 1995). Homodimerization of gp130
(Murakami et al., 1993) induced by a complex of interleukin
6 (IL-6) plus soluble IL-6 receptor is also sufficient to sustain
ES cell self-renewal (Yoshida et al., 1994).
LIF mRNA is present in the trophoblast cells of the
blastocyst and both LIF-R and gp130 mRNAs are expressed
in the pluripotential cells of the inner cell mass (ICM)
(Nichols et al., 1996). However, the contribution of signal-
ing through this receptor system to stem cell renewal and
expansion during early embryogenesis is unclear. The find-
ing that embryos lacking either LIF-R (Li et al., 1995; Ware
et al., 1995) or gp130 (Yoshida et al., 1996) can develop up to
and beyond gastrulation implies that alternative classes of
factor(s) are competent to sustain formation and expansion
of the inner cell mass/epiblast in vivo.
ES cell cultures are potentially a rich source of factors
that regulate embryonic differentiation (Heath and Smith,
1988). To establish an assay system for detecting alternative
factors that may regulate ES cell self-renewal, we generated
ES cells in which both copies of the lif gene are deleted. We
report here that differentiated LIF-deficient ES cells synthe-
size a soluble activity that inhibits ES cell differentiation.
This activity is distinct from all previously characterized ES
cell maintenance factors.
MATERIALS AND METHODS
Targeting Vectors
Genomic clones spanning the murine DIA/LIF gene were iso-
lated from a strain 129 mouse lambda library, the restriction
pattern established and a 13-kb HindIII–HindIII fragment sub-
cloned. In the targeting constructs the entire structural gene was
deleted by digestion with BamHI and replaced by (i) a BglII–BamHI
fragment containing a hprt minigene driven by the mouse pgk-1
promoter (Selfridge et al., 1992), or (ii) a BglII–BglII fragment con-
taining a hygromycin-resistance gene (hph) driven by the pgk-1
promoter (te Riele et al., 1990). Targeting constructs were released
from the plasmid backbone by digestion with SalI or HindIII re-
spectively prior to electroporation.
ES Cell Culture and Chimera Production
CP1 ES cells (Bradley et al., 1984), CGR8 ES cells (Mountford et
al., 1994), HPRT-deficient E14TG2a ES cells (Hooper et al., 1987),
and derivatives were maintained without feeders on gelatin-coated
plastic in Glasgow modification of Eagle’s medium (GMEM)
supplemented with 0.1 mM b-mercaptoethanol, 10% fetal calf
serum and 100 units/ml murine LIF (Smith, 1991). Oct-4-bgeo-
targeted indicator ES cells were generated as reported (Mount-
ford et al., 1994). Induction of ES cell differentiation with
3-methoxybenzamide (MBA) or with retinoic acid were carried out
essentially as described (Smith, 1991). Standard histochemical
staining protocols were employed for the visualization of alkaline
phosphatase and b-galactosidase activity. Microinjection of ES cells
into strain C57BL/6 blastocysts was performed according to stan-
dard procedures (Robertson, 1987).
ES Cell Transfection, Drug Selection, and
Screening for Recombinants
Targeting constructs were introduced into ES cells by electropo-
ration of 108 cells with 150 mg DNA in 0.8 ml phosphate-buffered
saline (PBS). Cells were given a single pulse of 800 V at 3 mF and
then plated onto 9-cm-diameter tissue culture plates at 2 3 106 and
5 3 106 cells per plate for selection in HAT and hygromycin B,
respectively. After overnight incubation, selection was applied in
either HAT or hygromycin B (100 mg/ml). HAT selection was not
maintained for the second round of targeting in order that recom-
bination events at either allele could be detected. Selective me-
dium was renewed every other day for 10 days when individual
colonies were picked and expanded for analysis and storage as
described (Ure et al., 1992). Primary screening was carried out on
DNA prepared from individual clones embedded in low-melting-
point agarose. DNAs were restricted with EcoRI and analyzed by
Southern hybridization with a 32P-labeled probe outwith the ho-
mology region (see Fig. 1). Positive clones were expanded further for
phenol-extracted DNA preparation. Ten micrograms of EcoRI- and
BamHI-restricted DNA was then hybridized to 39 and 59 external
probes, respectively.
RNA Isolation and Analysis
Total RNA was isolated by the acid–phenol extraction method
(Chomczynski and Sacchi, 1987). Poly(A1)-enriched RNA was
prepared by a single pass over oligo(dT)–Sepharose. Northern hy-
bridization was carried out according to standard procedures using
32P-labeled probes (Sambrook et al., 1989). RNase protection anal-
ysis of LIF mRNA expression was performed as described (Robert-
son et al., 1993).
Cytokines, Cell Lines, and Antibodies
Mouse LIF was produced by transient transfection of Cos cells as
described (Smith, 1991). Recombinant rat CNTF and human on-
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costatin M were purchased from Genzyme. Recombinant human
interleukin-6 was a generous gift from Dr. Yasukawa (TOSOH
Biochemicals) and recombinant mouse cardiotrophin-1 was pro-
vided by Dr. D. Pennica (Genentech). Soluble human interleukin-6
receptor was produced in CHO cells and supernatant used at
dilutions between 1 in 20 and 1 in 100 (Yasukawa et al., 1990). The
B9 hybridoma cell line was used for quantification of IL-6 or IL-11
in culture supernatants (Aarden et al., 1987; Burger and Gramatzki,
1993). Neutralizing polyclonal anti-LIF antiserum was raised by
immunisation of a rabbit with purified recombinant mouse LIF
coupled to Sepharose beads (Neophytou et al., 1997). The neutral-
izing anti-mouse IL-6 receptor monoclonal antibody RS13 has been
described previously (Saito et al., 1991). Monoclonal (4-68) and
neutralizing polyclonal anti-CNTF antibodies (Sendtner et al.,
1992; Stockli et al., 1992) were gifted by Dr. M. Sendtner. Rat
monoclonal antibodies Rx187 and Rx435 against mouse gp130 will
be described in detail elsewhere (Saito et al., in preparation).
Preparation of Nuclear Extracts and Band-Shift
Assays
One day after plating (1 3 106 cells per 60 mm dish), ES cells
were washed with PBS and refed with medium lacking cytokines.
The following day, cells were stimulated with IL-6 (100 ng/ml plus
soluble receptor) or LIF (100 U/ml) or ammonium sulfate fraction-
ated ESRF (10% v/v) for 20 min, washed with ice-cold PBS, scraped
off the plates, and collected by centrifugation. Nuclear extracts
were prepared by the method described (Gobert et al., 1996) except
that protease inhibitors were omitted from the cell lysis buffer.
Protein concentrations of nuclear extracts were determined using a
Bradford assay (BioRad). Aliquots (2 mg) of nuclear extract were
incubated with 0.25 ng of 32P-labeled double-stranded SIEm67
oligonucleotide probe (Sadowski et al., 1993) in binding buffer (20
mM Hepes, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.05%
NP-40, 10% glycerol, 2 mg/ml poly(dI–dC) and 1 mg/ml BSA) for 20
min at room temperature. Binding reactions were resolved by
electrophoresis on a prerun 5% polyacrylamide gel in 0.25x TBE for
3 h. Gels were fixed in 10% acetic acid, dried under vacuum, and
subjected to autoradiography.
RESULTS
Generation of LIF-Deficient ES Cell Lines
Clonal propagation of ES cells is dependent upon supple-
mentation of the culture medium with LIF (Smith and
Hooper, 1987; Smith et al., 1988; Williams et al., 1988) or
provision of LIF by a feeder layer (Martin and Evans, 1975;
Rathjen et al., 1990b; Stewart et al., 1992)). At higher
densities, however, withdrawal of LIF does not result in the
complete elimination of stem cells (Rathjen et al., 1990a;
Smith, 1992). We have previously presented evidence for
feedback regulation of stem cell renewal whereby the
elevated synthesis of LIF by newly differentiated ES cells
allows expansion of residual undifferentiated stem cells
(Rathjen et al., 1990a). To reveal any additional self-renewal
activities that may be present in ES cell cultures, it is
therefore first necessary to abolish LIF function. This was
achieved by two rounds of targeted gene deletion. ES cells in
which one copy of the lif gene was inactivated were
generated using a replacement vector in which the entire
coding sequences are deleted and replaced by a selectable
hprt minigene (Fig. 1A). After transfection into HPRT-
deficient E14TG2a cells, HAT-resistant ES cell clones
which had undergone homologous recombination were
identified by DNA hybridization analysis using a probe
external to the 39 arm of homology (Fig. 1B). To verify the
expected replacement event, DNAs from positive clones
were digested with the appropriate enzyme and hybridized
to a 59 external probe (Fig. 1B). In total, 11 correctly targeted
clones were identified from a primary screen of 89 colonies.
Germline chimeras were generated from several of these
clones.
One germline-competent clone, D6, was used for the
deletion of the second allele. A hygromycin resistance
cassette was substituted for the hprt marker in the targeting
vector (Fig. 1A). In parental cells this construct gave rise to
homologous replacement events at a frequency (10%) com-
parable to that obtained with the hprt vector. This second
construct was electroporated into the D6 clone and trans-
fectants were isolated by selection in hygromycin B. Three
classes of homologous recombinant were identified among
162 colonies screened: recombination into the previously
targeted allele had occurred in 15% of clones; insertion into
either the 59 or the 39 homology region of the wild-type
allele (Fig. 1B) was detected in four cases; and only three
clones had undergone replacement of the wild-type allele.
Deletion of LIF coding sequences was confirmed for these
three clones by the absence of hybridization with a full-
length cDNA probe, whereas clones which had undergone
recombination into only one homology arm retained the
LIF coding sequences (Fig. 1B).
The absence of LIF mRNAs in double knock-out ES cell
lines was confirmed using a sensitive ribonuclease protec-
tion analysis (Robertson et al., 1993). As shown in Fig. 1C,
following induction of differentiation the parental
E14TG2a ES cells express relatively high levels of mRNAs
encoding both matrix-associated and diffusible forms of LIF
(Rathjen et al., 1990b), as previously described for other ES
cell lines (Rathjen et al., 1990a). In contrast, no protected
fragment could be detected in RNA preparations from
undifferentiated or differentiated double knock-out ES cells
(lanes 3–5). These experiments confirm unambiguously
that the LIF deletion is a null mutation. The similar
phenotype of two independent clones, named D1C2 and
D7A3, that were isolated from separate plates during the
drug selection, is reported in the following experiments.
Capacity of LIF-Negative ES Cells for Integration
and Differentiation in Vivo
To assess their developmental potential, LIF-deficient ES
cell clones were used to generate chimaeras. DIC2 and
D7A3 ES cells were injected into C57BL/6 blastocysts and
chimeric offspring were produced. Chimeras showed high
ES cell contribution as judged by the level of 129/Ola-
derived sandy coat color. This was confirmed by the deter-
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FIG. 1. Molecular description of LIF-negative ES cells. (A) Restriction maps of the lif locus and targeting constructs. Restriction enzyme
sites are: B, BamHI; E, EcoRI; H, HindIII; Bg, BglII. Bars represent the exons. D and M indicate the alternative first exons of the diffusible
and matrix-associated isoforms of LIF, respectively. The narrow bar represents the 39 untranslated region. The length of homologous
isogenic DNA in the targeting constructs is indicated. The hprt minigene and hph (HygR) gene, are in the same transcriptional orientation
as the lif locus. External probes and expected length of fragments recognized by these probes following homologous recombination events
are indicated. (B) Southern blot analysis of ES cell DNA obtained from (1) wild-type cells, (2) cells targeted with the HPRT replacement
vector, (3–4) heterozygous cells targeted with the HygR vector without replacement of lif sequences, and (5) correct double replacement
clone. Panels show (I) Digest with EcoRI, hybridization to 39 external probe. (II) Digest with BamHI, hybridization to 59 external probe. (III)
Digest with EcoRI, hybridization to LIF full-length coding sequence probe. The positions of the wild-type and disrupted alleles are indicated.
(C) Ribonuclease protection of LIF transcripts in total RNA from (1) undifferentiated parental ES cells, (2) MBA-induced differentiated
parental ES cells, (3) undifferentiated D1C2 lif 2/2 ES cells, (4) MBA-induced differentiated D1C2 lif 2/2 cells, and (5) differentiated
D7A3-PE lif 2/2 cells. Ribonuclease protection assays were performed on 20 mg of total RNA. Protected fragments in the parental cell line
samples correspond to the D and M LIF transcripts (Rathjen et al., 1990b). GAPdh marks the loading control protection.
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mination of the degree of ES cell contribution to blood and
tail of five chimeric mice by glucose phosphate isomerase
isozyme analysis (not shown). Both clones contributed to
functional gametogenesis and germline offspring were ob-
tained harboring either of the disrupted alleles. Viable
homozygous LIF-deficient mice were generated and the
females found to be infertile as previously reported (Stewart
et al., 1992; Escary et al., 1993). These results establish that
the two rounds of selection applied to generate double
knock-out ES cell lines have not abolished their normal
developmental potential.
Stem Cell Renewal Can Occur in the Absence of
LIF
Previous studies have implicated expression of LIF in
autocrine and/or paracrine regulation of self-renewal in
differentiating ES cell cultures (Rathjen et al., 1990a; Smith
and Rathjen, 1991). The validity of this hypothesis was
examined by investigation of the capacity of LIF-deficient
ES cells to regenerate stem cell colonies following induc-
tion of differentiation. Wild-type, heterozygous, and ho-
mozygous mutant ES cells were induced to differentiate at
high cell density by exposure to 3-methoxybenzamide
(MBA) for 3 days (Smith, 1991). After an additional 4 days in
basal medium, the number of undifferentiated ES colonies
was determined by both morphological inspection and
alkaline phosphatase staining. As documented in Fig. 2A,
similar numbers of undifferentiated ES colonies were recov-
ered from the wild-type and two heterozygous ES cell
cultures. In contrast, the number of ES colonies was two- to
threefold lower for the two LIF-negative ES clones. This
decrease confirms that the autocrine and paracrine produc-
tion of LIF plays a major role in the maintenance of stem
cell renewal in differentiating ES cell cultures. Signifi-
cantly, however, stem cell renewal was not completely
abolished in the absence of LIF. Therefore an additional
mechanism for sustaining stem cell renewal factor is opera-
tive.
Inhibition of ES Cell Differentiation by a Soluble
Activity
To preclude the possibility that the culture conditions
imposed a selection for rare differentiation-defective vari-
ants, the capacity of LIF-deficient cells to support stem cell
propagation was further investigated in coculture assays.
Convenient indicator cell lines were generated by integra-
tion of a b-galactosidase reporter gene into the oct-4 locus of
LIF-negative ES cells by homologous recombination using
the efficient IRES-containing construct described previ-
ously (Mountford et al., 1994). The expression of
b-galactosidase in such targeted clones is restricted to
undifferentiated stem cells. The indicator cells were plated
on layers of MBA-induced differentiated wild-type or lif
2/2 clones. After 4 days, the number of undifferentiated ES
cell colonies derived from the indicator population was
determined by staining for b-galactosidase activity. Once
again, the results indicate that the capacity of LIF-deficient
differentiated cells to inhibit ES cell differentiation is
reduced relative to the parental cell line, but is not abol-
ished (Fig. 2B). Similar results were obtained using retinoic
acid-induced differentiated cells as the feeder layer (not
shown).
To determine whether the effect was due to a diffusible
factor, a second kind of coculture experiment was under-
taken in which the indicator cells were plated on a micro-
porous insert above the layer of differentiated cells. The
insert membrane prevents cell–cell contact between the
two cell populations but allows the access of diffusible
factors. Both parental and Oct-4-tagged ES cells were used
as indicators, with staining for alkaline phosphatase and
b-galactosidase, respectively. Comparable results were ob-
tained in both cases. Data for the Oct-4-tagged indicators
are presented in Fig. 2C. The greater activity in wild-type
cultures was significantly reduced in the presence of neu-
tralizing anti-LIF serum (Fig. 2C, lane 5), but was not
eliminated. This indicates that wild-type cells also synthe-
size active factors other than LIF. The residual activity in
the presence of anti-LIF was similar to that produced by
LIF-negative cells which further suggests that expression of
the responsible factor is not significantly up-regulated in
the latter.
These data establish that a soluble factor(s) other than LIF
is able to prevent ES cell differentiation and is synthesized
by both wild-type and LIF-deficient differentiated cells.
Isolation of a Differentiated Cell Line Expressing
High Levels of Stem Cell Renewal Activity
To facilitate characterization of the stem cell renewal
activity, differentiated cell cultures were established from
embryoid body outgrowths of the D7A3 LIF-negative ES
cells. After 6 days in suspension, aggregates were plated on
gelatin-coated plates and maintained for an additional 4
days. Various differentiated cell types were then picked and,
where possible, expanded. Several of these cultures pro-
duced levels of activity that were readily detectable in their
supernatants. Such cultures were characterized by the pre-
dominant presence of migratory polygonal cells which
underwent transition to a refractile rounded appearance at
high cell density. This appearance is typical of mouse
parietal endoderm cells in vitro (Van de Stolpe et al., 1993).
Purified populations of these cells could be derived by
subcultivation. One culture, named D7A3-PE, was ex-
panded and subsequently could be propagated indefinitely.
Consistent with a putative parietal endoderm identity,
D7A3-PE cells expressed transcripts for two marker pro-
teins of this cell type, tissue plasminogen activator and
SPARC (Marotti et al., 1982; Holland et al., 1987). D7A3-PE
cells constitutively produce high levels of a soluble factor
that can maintain undifferentiated ES cells (Fig. 3A).
ES cells cultured in D7A3-PE conditioned medium form
tightly packed, multilayered, colonies (Fig. 3A). They con-
153ES Cell Regulatory Factor
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
tinue to express markers of the undifferentiated state such
as alkaline phosphatase (Bernstine et al., 1973), Oct4-linked
b-galactosidase (Mountford et al., 1994), and Rex-1 mRNA
(Rogers et al., 1991) (Fig. 3B). Subtle differences are apparent
compared with ES cells maintained in the presence of LIF,
however. First, the efficiency of stem cell colony formation
is rather lower (see data in Figs. 4 and 5A). Second, the
colonies are more rounded and readily detach from the
substratum. Finally, colony size does not increase apprecia-
bly after about 4 days. Interestingly, cells grown in LIF plus
D7A3-PE medium initially show rounded up colony mor-
phology. However, growth rate is maintained under these
conditions and after several days the majority of colonies
spread out and are then indistinguishable in size and
morphology from cells grown in LIF alone. This suggests
that the reduced growth in conditioned medium is not
attibutable to nutrient limitation (see also Discussion).
Cells grown in D7A3-PE conditioned medium and subse-
quently transferred into LIF-supplemented medium also
convert to typical undifferentiated ES cell morphology and
growth characteristics. In contrast, cells transferred directly
from conditioned medium to nonsupplemented medium
undergo overt differentiation into large, flattened, nonpro-
liferative cells, as are produced when ES cells previously
cultured in LIF are placed in nonsupplemented medium
(Smith et al., 1988; Smith, 1991). These observations indi-
cate that culture of ES cells in D7A3-PE conditioned me-
dium maintains their undifferentiated nature and does not
transform or respecify them.
The active component(s) in D7A3-PE conditioned me-
dium is dialyzable, can be concentrated more than 20-
fold by ultrafiltration and is destroyed by incubation with
trypsin, consistent with a proteinaceous macromolecule.
Activity is lost on heating to 50°C or acidification below
pH 3. Quantitative recovery is achieved after precipita-
tion with 35% (v/v) saturated ammonium sulfate and
reconstitution in 2 M urea. Interestingly, we have so far
been unable to dissociate the maintenance of undifferen-
tiated stem cells from the distinctive rounded colony
morphology and limitation on colony growth observed in
conditioned medium, even when active fractions are
added in excess. We have provisionally given the name ES
cell renewal factor (ESRF) to the active component(s)
produced by D7A3-PE cells.
FIG. 2. ES cell self-renewal in the absence of LIF. (A) Stem cell
rescue in LIF-deficient cultures. ES cells (105 cells/35 mm well)
were induced to undergo differentiation by exposure to 3 mM MBA
for 72 h. After an additional 4 days of culture in normal medium
without MBA or DIA/LIF, the number of undifferentiated ES
colonies was determined by staining for alkaline phosphatase
activity. (1) Parental E14TG2a ES cells, (2) D1C2 null ES cells, (3)
D7A3 null ES cells, (4) heterozygous ES cells with a hygR disrupted
allele, and (5) heterozygous ES cells with an HPRT disrupted allele.
(B) Direct inhibition of ES cell differentiation by LIF-deficient cells.
ES cells were induced to undergo differentiation as described in A.
After 72 h induction with MBA, 2 3 103 LIF-deficient-Oct-4-bgeo
indicator ES cells were added to the cultures. After an additional 4
days in MBA-free, LIF-free medium, the number of undifferentiated
ES cell colonies was determined by staining for b-galactosidase
activity. Differentiated cells used as feeder layers are: (1) parental
E14TG2a, (2) D1C2 null cells, (3) D7A3 null cells, and (4) no feeder
layer. (C) Soluble character of the self-renewal activity. Experimen-
tal procedure as in B except that indicator cells (104) were plated
onto microporous inserts (transwells) instead of directly on the
differentiated cell layer. Conditions (1–4) are as in B, (5) differenti-
ated E14TG2a feeder layer in the presence of neutralizing anti-
mouse LIF antiserum. Data in all panels are mean (6SD) colony
numbers determined from duplicate wells. Each experiment was
independently repeated at least once and gave qualitatively repro-
ducible findings.
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ESRF Does Not Act through IL-6R or LIF-R
We have previously shown that IL-6 can substitute for LIF
in the maintenance of ES cell pluripotency in vitro (Yoshida et
al., 1994). Addition of a soluble form of IL-6 receptor is also
required, however, because ES cells do not express the IL-6-
specific receptor component (Saito et al., 1992). The sensitive
B9 cell proliferation assay (Aarden et al., 1987) was employed
to investigate the possible presence of IL-6 in D7A3-PE con-
ditioned medium. A weak mitogenic response was detected,
equivalent to a concentration of less than 5 pg/ml IL-6.
Complete inhibition of this activity in the presence of the
anti-IL-6R blocking antibody RS13 (Saito et al., 1991) con-
firmed that it was attributable to IL-6. The effect of D7A3-PE
cell conditioned medium on ES cells was not modified by the
addition of RS13, however (Fig. 4A). Thus the ES cell self-
renewal activity is not due to IL-6/sIL-6R.
ES cell propagation can be sustained by CNTF (Conover
et al., 1993; Wolf et al., 1994). The presence of CNTF in
FIG. 3. Undifferentiated character of ES cells propagated in medium conditioned by D7A3-PE cells. (A) Representative ES cultures
observed following culture for 4 days in the absence of LIF in either 50% (v/v) D7A3-PE cell conditioned medium (top) or standard medium
(bottom). (B) Expression of Rex-1 mRNA by CP1 cells maintained for 4 days (1) in 50% (v/v) D7A3-PE cell conditioned medium, (2) in
standard medium, and (3) in standard medium supplemented with 100 U/ml LIF.
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D7A3-PE cell conditioned medium was examined both by
specific immunodepletion with the 4-68 anti-CNTF mono-
clonal antibody (Stockli et al., 1992) and by the use of a
neutralizing anti-CNTF antiserum (Sendtner et al., 1992).
Neither treatment affected the ability of D7A3-PE cell
conditioned medium to inhibit ES cell differentiation (not
shown). Two further LIF-related cytokines, OSM and CT-1,
have been demonstrated to support ES cell propagation
(Nichols et al., 1994; Rose et al., 1994; Pennica et al., 1995).
It is probable that other factors exist that act through
receptor complexes containing LIF-R (Li et al., 1995) and
could similarly support ES cell growth. To determine de-
finitively whether the effect of ESRF was mediated through
LIF-R, we examined activity on LIF-R-deficient LRKOh34
ES cells (Li, in preparation, Li et al., in preparation). These
cells were generated by two rounds of homologous recom-
bination. They are maintained as self-renewing stem cells
using IL-6/sIL-6R but show no self-renewal response to LIF,
CNTF, CT-1 or OSM. As shown in Fig. 4, LRKOh34 ES cells
produce alkaline phosphatase-positive stem cell colonies in
response to ESRF, with efficiency comparable to that of
heterozygous or wild-type (not shown) ES cells. This finding
establishes that ESRF does not operate through a LIF-R
receptor complex.
ESRF Acts Independently of gp130
All cytokines described to date that are capable of sus-
taining ES cell self-renewal act through receptor complexes
containing the gp130 signal transducer (Yoshida et al.,
1994; Pennica et al., 1995). Monoclonal antibodies have
been raised against mouse gp130 that are capable of block-
ing gp130-mediated signal transduction (Saito et al., in
preparation). In the presence of Rx435 or Rx187 antibodies,
cellular responses to the IL-6/LIF family of cytokines are
inhibited (Wollert et al., 1996; Saito et al., in preparation).
The effect of neutralizing gp130 antibodies on the main-
tenance of ES cell self-renewal by D7A3-PE conditioned
medium was investigated. Rx435 efficiently blocks cyto-
kine signaling mediated via either hetero- or homodimer-
ization of gp130 (Saito et al., in preparation). This antibody
inhibited ES cell self-renewal in response to LIF, CNTF,
OSM, CT-1, or IL-6/sIL-6R, in all cases causing differentia-
tion of the ES cells. The antibody had no effect, however, on
the activity of ESRF either in conditioned medium or
fractionated. The efficient production of b-galactosidase-
positive stem cell colonies by Oct-4-targeted cells in ESRF
in the presence of Rx435 is documented in Fig. 5A. The
morphology of undifferentiated alkaline phosphatase-
positive colonies of wild-type CP1 ES cells in ESRF in the
presence and absence of Rx435 is shown in Fig. 5B. A
second blocking antibody, Rx187, also failed to inhibit
ESRF action (not shown). The results of these experiments
argue that ESRF action is not mediated via a gp130 receptor
complex.
ESRF Does Not Activate STAT3
Stimulation of gp130 receptor complexes leads to activa-
tion of the latent transcription factor STAT3. Inactive
cytoplasmic STAT3 is recruited to phosphorylated docking
FIG. 4. ESRF does not act through IL-6 receptor or LIF receptor.
(A) Neutralizing anti-IL6 receptor antibody does not block ESRF
activity. CP1 ES cells were plated at 5000 cells per 35-mm well in
standard medium or in 50% (v/v) D7A3-PE cell conditioned me-
dium in the absence or presence of 10 mg/ml neutralizing anti-IL-6
receptor antibody RS13. (In parallel experiments RS13 completely
blocked IL-6-stimulated DNA synthesis in B9 cells.) After 5 days
the number of undifferentiated ES cell colonies was determined by
staining for alkaline phosphatase. Data are mean (6SD) stem cell
colony numbers determined from duplicate wells. (B) Activity of
ESRF on LIF-receptor negative ES cells. ES cells with neither (1/1),
one (1/2), or both (2/2) copies of the lifr gene disrupted were
cultured at clonal density (1000 cells per 35 mm well) in medium
with no addition, supplemented with LIF (100 U/ml), or supple-
mented with ammonium sulfate-fractionated ESRF (10% v/v).
Fixed cultures were stained for alkaline phosphatase and the
numbers of undifferentiated colonies scored. Data are averaged
from two independent experiments.
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sites on the actively signaling LIF-R and gp130 molecules
(Lutticken et al., 1994; Stahl et al., 1995). Receptor-
associated STAT3 is then activated by phosphorylation by
JAK kinases whereupon it translocates to the nucleus and
directs target gene transcription. In ES cells, receptor en-
gagement with and activation of STAT3 are essential for
self-renewal signalling from gp130 (Niwa et al., 1998). Gel
shift analysis was used to examine whether ESRF likewise
induces STAT3 DNA binding activity. ESRF was used at a
concentration that gives a maximal self-renewal response.
The data presented in Fig. 6 show that, in contrast to the
strong stimulation by IL6/sIL6R, there is no detectable
activation of STAT3 in response to ESRF.
Production of Chimeras from ES Cells Maintained
with ESRF
ESRF sustains the undifferentiated phenotype of ES cells
in vitro. However, proliferation is relatively limited and
cultures cease to expand appreciably after about 4 days.
This contrasts with cultures propagated in the presence of
LIF which undergo a continuous increase in stem cell
numbers. To determine whether ES cells maintained in
ESRF remained capable of contributing to chimeras, cells
were plated at low density (5000 cells/10 mm well), cul-
tured in the presence of ESRF, and then microinjected into
mouse blastocysts. The CGR8-derivative ES cell line ZIN40
was used because this carries a widely expressed nuclear
localized b-galactosidase marker (Mountford, 1995). ZIN40
ES cells were cultured for 5 days in ammonium sulfate-
fractionated ESRF and then trypsinized and transferred to
LIF-containing medium for an additional 5 days to facilitate
expansion of the stem cells prior to blastocyst injection.
Cells plated in control nonsupplemented medium under-
went complete differentiation and did not give rise to ES
cell colonies upon replating in the presence of LIF. Cells
FIG. 5. Lack of effect of neutralising anti-gp130 antibody on the
activity of ESRF. (A) Oct-4-bgeo indicator ES cells were plated at
500 cells/5 mm well and cultured for 4 days in the absence or
presence of 30 mg/ml Rx435 neutralizing anti-mouse gp130. The
numbers of stem cell colonies produced were determined by
staining for b-galactosidase activity. Cells were cultured in stan-
dard medium with the following factors: (1) no addition, (2) murine
LIF, 2.5 U/ml, (3) OSM, 2.5 ng/ml, (4) D7A3-PE cell conditioned
medium (concentrated by ultrafiltration and used at 1/20 dilution).
Data are mean (6SD) colony numbers per well determined from
duplicate wells. Comparable results were obtained in separate
experiments on two independent indicator cell lines. (B) Parental
CP1 ES cells were cultured as in A for 4 days and then fixed and
stained for alkaline phosphatase. In ESRF-supplemented medium,
rounded stem cell colonies formed with equal efficiency in the
absence or presence of Rx435.
FIG. 6. STAT3 DNA binding activity is not induced by ESRF.
Electrophoretic mobility shift assay of STAT3 binding activity in
nuclear extracts prepared from lifr 2/2 LRKOh34 ES cells un-
treated or stimulated for 20 min with IL-6 (100 ng/ml plus sIL-6
receptor), LIF (100 U/ml), or ESRF (ammonium sulfate fractionated,
10% v/v).
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plated in ESRF, however, remained undifferentiated as
described above and engendered numerous alkaline
phosphatase-positive stem cell colonies on replating. Cells
from these cultures contributed extensively to chimeras as
determined by widespread presence of b-galactosidase-
positive cells in midgestation embryos (not shown). These
chimeric embryos were morphologically normal. The level
of ZIN40 contribution was comparable to that obtained
from parallel injections of cells maintained in LIF only.
The ability to generate liveborn chimeras was then inves-
tigated. LIF-receptor-negative ES cells were employed to
eliminate any contribution of endogenous LIF signaling.
LRKOh34 cells were plated at clonal density (500 cells/10
mm well) and cultured for 7 days in medium supplemented
with ESRF, by which time parallel cultures in nonsupple-
mented medium had completely differentiated. Stem cell
colonies persisted in the presence of ESRF, although some
differentiation was also apparent. Individual colonies were
picked, dissociated, and injected directly into blastocysts.
Liveborn pups exhibiting overt coat-color chimerism were
generated (Table 1). Both the number of chimeras and the
proportion of ES cell contribution were lower than gener-
ally obtained using parental ES cells maintained in LIF.
This may in part reflect reduced efficacy of ESRF in the
absence of accompanying endogenous LIF-R stimulation, as
also indicated by the higher level of differentiation (see
Discussion). However, the LRKOh34 cell line also gives
relatively poor chimeras after routine maintenance in IL6/
sIL6R (Li et al., in preparation). In particular we have found
that highly chimeric pups rarely survive, probably reflect-
ing the lethal nature of the LIF-R deletion which is associ-
ated with profound neuronal losses and other abnormalities
(Li et al., 1995; Ware et al., 1995).
Chimeras were therefore also generated from the lifr 1/1
IOUD2 ES cell line. This E14TG2a-derived cell line carries
a targeted Oct-4bgeo stem cell marker (Mountford et al.,
1994). Cells were plated at clonal density and cultured for 7
days in the presence of fractionated ESRF. Cells were then
injected directly or incubated in the presence of LIF for an
additional 24 h prior to blastocyst injection. Duplicate
cultures were fixed and stained for stem cell-specific
b-galactosidase activity (Mountford et al., 1994). This con-
firmed the predominant presence of undifferentiated stem
cell colonies in ESRF-supplemented cultures and their
absence in nonsupplemented control cultures. Single clones
were picked from the unstained cultures and microinjected
as above. Liveborn chimeras with extensive ES cell-derived
coat-color contribution were generated (Table 1). In subse-
quent matings with MF1 albino (c/c) females four of five
male chimeras have transmitted the ES cell-derived chin-
chilla (cch/cch) coat-color marker. Although preincubation
with LIF appears to enhance the contribution to chimeras
(Table 1), it is noteworthy that one of the germline trans-
mitters was from a clone injected directly from ESRF
culture. These results establish that ESRF maintains the
full developmental potency of ES cell clones.
DISCUSSION
Mouse ES cells are generally assumed to be equivalent to
the pluripotential stem cells of the ICM/epiblast in the
peri-implantation embryo. They retain the unique develop-
mental potentials of this lineage: when recombined with a
host embryo, ES cells are able to integrate into normal
embryogenesis, generate the full repertoire of differentiated
cell types, and form functional gametes (Bradley et al.,
1984). However, pluripotent epiblast cells in vivo are main-
tained only for a finite period between E4 and E8. ES cells in
contrast can undergo unlimited expansion. This property is
not cell autonomous, but is dependent on extrinsic factor(s)
in the absence of which the ES cells differentiate. In
particular, clonal expansion of undifferentiated pluripoten-
tial ES cells is not possible without coculture on a feeder
layer or cytokine supplementation of the medium.
The first described ES cell maintenance factor was the
cytokine LIF (Smith and Hooper, 1987; Smith et al., 1988;
Williams et al., 1988). The small group of LIF-related cyto-
kines now shown to support ES cell propagation all act
through cell surface receptor complexes that contain LIF-
receptor and gp130 (Yoshida et al., 1994; Pennica et al., 1995)
and induce activation of the latent transcription factor
STAT3. Significantly, however, although both LIF and LIF-
receptor components are expressed in the early mammalian
TABLE 1
Production of Chimeras from ES Cells Maintained in ESRF
Cell line Culture regime Embryos/pups Chimeras (%) Germline
Zin40 5d LIF 3 5d LIF 20a 11 (55%) N/A
Zin40 5d ESRF 3 5d LIF 18a 14 (78%) N/A
LRKOh34 7d ESRF 37b 8 (22%) ND
IOUD2 7d ESRF 27b 2 (7%) 1
IOUD2 7d ESRF 3 1d LIF 11b 7 (64%) 3
a Embryos recovered at E10 and analyzed by staining for b-galactosidase activity.
b Liveborn pups examined for coat-color chimerism at weaning. Germline transmission of the strain 129OlaHsd ES cell coat-color marker
(cch/cch) was determined by mating male chimeras with MF1 albino (c/c) females. N/A, not applicable; ND, not determined.
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embryo (Nichols et al., 1996), they appear not to be essential
for normal development of the epiblast. Targeted inactivation
of the lif (Stewart et al., 1992), lifr (Li et al., 1995; Ware et al.,
1995), or gp130 (Yoshida et al., 1996) genes does not prevent
formation and expansion of the epiblast with subsequent egg
cylinder development and gastrulation. There is a theoretical
possibility that LIF-R and gp130 receptor components might
function in a redundant fashion by interaction with alterna-
tive partners. However, we have found that double mutants
lacking both LIF-R and gp130 also progress through gastrula-
tion and develop to at least midgestation (unpublished data).
Initial formation and growth of the epiblast also appears
normal in Stat3 null embryos, although subsequent gastrula-
tion is disrupted (Takeda et al., 1997). The implication of
these findings is that an alternative pathway may be primarily
responsible for maintaining epiblast proliferation and pluripo-
tency in vivo.
We reasoned that mouse ES cells and/or their progeny
might themselves be a source of a factor(s) that sustained
their self-renewal. To attempt to uncover such a factor,
endogenous expression of LIF was eliminated by targeted
gene deletion. The resultant LIF-negative ES cells retained
full pluripotency in vitro and in vivo, but as anticipated
showed reduced persistence of stem cells and regeneration
of undifferentiated colonies after induction of differentia-
tion. Nonetheless, limited self-renewal activity was still
apparent and could be ascribed to a soluble macromolecule,
which we have named ESRF. ESRF is active on all mouse ES
cells tested. Clonal propagation followed by chimera pro-
duction show that ESRF is competent to sustain the full
pluripotential character of ES cells and their unique capac-
ity to integrate into embryonic development. ESRF operates
via a different receptor from the LIF-related cytokines that
does not include either LIF-R or gp130. It is therefore
distinct from any previously described ES cell regulator.
Most significantly, the demonstration that ESRF does not
induce STAT3 activation points to the existence of a new
intracellular pathway for signaling self-renewal.
Intriguingly, in addition to the distinctions in receptor
utilization and signal transduction, the response of ES cells
to ESRF and LIF also appear to differ at the level of cellular
phenotype. ES cells maintained in the presence of LIF form
relatively flattened colonies on gelatin-coated plastic
(Smith, 1991). In contrast, both conditioned medium and
partially purified ESRF induce formation of rounded colo-
nies of very tightly packed cells that adhere poorly to the
gelatin-coated culture surface. After an initial 3–4 days,
these colonies cease expansion if maintained in the pres-
ence of ESRF alone. However, they resume normal growth
and morphology when transferred to LIF-supplemented
medium. The proliferative and morphological effects of LIF
are also observed in the continued presence of ESRF. This
suggests that ESRF preparations do not contain an inhibitor
of ES cell growth or antagonist of LIF action. The distinct
morphological and growth inhibitory features of ESRF
preparations therefore most likely result from a direct effect
of ESRF on ES cell phenotype.
Given the evidence that ESRF and LIF do not act in the
same way, it is possible that these two pathways may
combine synergistically. In this regard it is noteworthy that
the period for which undifferentiated ES cells can be main-
tained by ESRF alone appears to be reduced in the case of
LIF-receptor-negative ES cells. This may reflect a lack of
synergy between ESRF and endogenously expressed LIF and
LIF-related cytokines.
Even in the presence of LIF, the appearance of undiffer-
entiated ES cells can vary considerably. This occurs both
stochastically and according to culture conditions, for ex-
ample, whether the cells are maintained on feeders, gelatin,
or plastic. These morphological changes are reversible and
without discernible impact on pluripotency (A.G.S., unpub-
lished data). Such variations in ES cell morphology may
reflect the phenotypic transitions experienced by epiblast
cells in vivo, which convert from a compact aggregate at the
time of implantation to an epithelial monolayer in the egg
cylinder. Perhaps the particular morphology associated
with culture in ESRF may reflect a discrete stage in ICM/
epiblast development.
The apparently self-limiting effect of ESRF on stem cell
proliferation may also be relevant to events in the embryo.
The mouse epiblast undergoes a dramatic expansion in the
36 h immediately following implantation (Snow, 1976).
This period of rapid proliferation is finite, as is the overall
period for which pluripotent stem cells persist in the egg
cylinder (Solter et al., 1970; Lawson et al., 1991). However,
the ready formation of teratocarcinomas by ectopically
grafted epiblast (Solter et al., 1970; Diwan and Stevens,
1976) indicates that these cells retain extensive prolifera-
tive capacity. The mechanisms which suppress this prolif-
erative potential in the embryo are unknown but are critical
for normal growth and differentiation and the prevention of
malignancy. The properties of ESRF suggest that it could
play an important role in regulation of the epiblast, by
maintaining pluripotency but at the same time restraining
proliferation. It is noteworthy that D7A3-PE cells express
characteristics of parietal endoderm, suggesting that ESRF
may be produced by extraembryonic endoderm cells and act
in a paracrine fashion in vivo.
Finally, ESRF may be relevant to the current efforts to
extend ES cell technology more widely, into other strains of
mice and into other species. ES cells are widely used as
vehicles for the introduction of genetic modifications into
the mouse germline (Robertson, 1986; Skarnes, 1990;
Hooper, 1992) and would be equally valuable in other experi-
mental animals, particularly the rat (Brenin et al., 1997). ES
cells can also be exploited to generate differentiated cell types,
and more importantly somatic stem cells (Hole et al., 1996;
Okabe et al., 1996). This may provide the basis for applica-
tions in cellular transplantation. An ability to derive human
ES cells could in principle provide an unlimited source of
donor cells and open new horizons in transplantation medi-
cine. However, to date it has not proven possible reproducibly
to establish ES cells from a broad range of mouse strains and
non-mouse species using LIF alone. This could reflect a
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requirement for an alternative factor to maintain efficiently
the self-renewing pluripotent phenotype. The potential con-
tribution of ESRF to ES cell derivation will therefore be a focus
of future investigation.
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